trending Market Intelligence /marketintelligence/en/news-insights/trending/dADL0kM0tXNt_uuFhgydaQ2 content esgSubNav
In This List

Immune Pharmaceuticals appoints COO

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Immune Pharmaceuticals appoints COO

Immune Pharmaceuticals Inc. appointed Tony Fiorino to the joint position of chief medical officer and COO of the company.

Fiorino previously served as president and CEO of Triumvira Immunologics, an immuno-oncology company developing an engineered T cell platform.